DC-CTL targeting carbonic anhydrase IX gene combined with iAPA therapy in the treatment of renal cell carcinoma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

DC-CTL targeting carbonic anhydrase IX gene combined with iAPA therapy in the treatment of renal cell carcinoma

Published:2021-11-02 Issue:11 Volume:17 Page:4363-4373
ISSN:2164-5515
Container-title:Human Vaccines & Immunotherapeutics
language:en
Short-container-title:Human Vaccines & Immunotherapeutics

Author:

Ma Heran¹²^ORCID,Tan Yi¹²^ORCID,Wen Dingke¹,Qu Na¹,Kong Qunfang¹,Li Kun³,Ma Suxia⁴,Zhang Jianhui¹^ORCID

Affiliation:

1. Qilu Cell Therapy Technology Co., Ltd, Jinan, China

2. Shandong Yinfeng Life Science Research Institute, Jinan, China

3. Department of Digestion, First Affiliated Hospital of Shandong First Medical University, Jinan, China

4. Heze Municipal Hospital, Heze, Shandong, China

Funder

Shandong Yinfeng Life Science Research Institute

First Affiliated Hospital of Shandong First Medical University

Publisher

Informa UK Limited

Subject

Pharmacology,Immunology,Immunology and Allergy

Link

https://www.tandfonline.com/doi/pdf/10.1080/21645515.2021.1955610

Reference26 articles.

1. Microarray gene expression profiling and analysis in renal cell carcinoma

2. Surveillance after radical or partial nephrectomy for localized renal cell carcinoma and management of recurrent disease

3. Renal-Cell Carcinoma

4. Cytoreductive nephrectomy for metastatic RCC in the era of targeted therapy

5. Recombinant Human Interleukin-2, Recombinant Human Interferon Alfa-2a, or Both in Metastatic Renal-Cell Carcinoma

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A case of response to combination treatment with TSA-DC-CTL immunotherapy and osimertinib in EGFR mutated advanced lung adenocarcinoma;Molecular Cancer;2024-08-09

2. The safety and anti-tumor effect of multiple peptides-pulsed dendritic cells combined with induced specific cytotoxic T lymphocytes for patients with solid tumors;Frontiers in Immunology;2023-10-24

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3